Search for 'an,phr: 296'

Guía Itinerario Formativo Tipo (GIFT) de Hematología y Hemoterapia (2022)

By Gómez Rojas, Sandra | Pérez Segura, Gloria | Castro Quismondo, Nerea | Sánchez Pina, José María. Madrid: Hospital Universitario 12 de Octubre, 2022 . 24 p. ; 30 cm..

Place Hold on Guía Itinerario Formativo Tipo (GIFT) de Hematología y Hemoterapia (2022)

Trastornos de la hemostasia. Anticoagulación

By González Medina, José | Ortiz Imedio, Juan | Castro Quismondo, Nerea | Martín Mola, Mª Ángeles. Madrid: MSD, 2016 . p. 1363-1386 , Formato Vancouver: González Medina J, Ortiz Imedio J, Castro Quismondo N, Martín Mola MA. Trastornos de la hemostasia. Anticoagulación. Pancitopenia. En: Suárez Pita D, Vargas Romero JC, Losada Galván I, Miguel Campo B, Catalán Martín P, Sánchez Moreno B, et al., editores. Manual de diagnóstico y terapéutica médica. 8ª ed. Madrid: MSD; 2016. p. 1363-86.

Place Hold on Trastornos de la hemostasia. Anticoagulación

Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3.

By Ayala Díaz, Rosa María | Canal López, Alicia | Castro Quismondo, Nerea | Grande García, Carlos | Martínez López, Joaquín | Rueda Fernández, Daniel. British Journal of Haematology, 2012 . 158(4):555-8. , Formato Vancouver: Martínez-López J, Castro N, Rueda D, Canal A, Grande C, Ayala R. Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3. Br J Haematol. 2012 Aug;158(4):555-8.

Place Hold on Use of Sorafenib as an effective treatment in an AML patient carrying a new point mutation affecting the Juxtamembrane domain of FLT3.

Anemia

By Castro Quismondo, Nerea | Pérez Rial, Gabriel. Madrid: MSD, 2012 . p. 1057-1069. , Formato Vancouver: Castro Quismondo N, Pérez Rial G. Anemia. En: Aguilar Herrero F, Bisbal Pardo O, Gómez Cuervo C, Lagarde Sebastián M, Maestro de la Calle G, Pérez-Jacoiste Asín MA, et al., editores. Manual de diagnóstico y terapéutica médica: Hospital Universitario 12 de Octubre. 7ª ed. Madrid: MSD; 2012. p. 1057-69.

Place Hold on Anemia

CALR mutations screening should not be studied in splanchnic vein thrombosis.

By Castro Quismondo, Nerea | Rapado Martínez, Inmaculada | Ayala Díaz, Rosa María | Martínez López, Joaquín. British journal of haematology, 2015 . 170(4):588-9. , Formato Vancouver: Castro N, Rapado I, Ayala R, Martínez López J. CALR mutations screening should not be studied in splanchnic vein thrombosis. Br J Haematol. 2015 Aug;170(4):588-9.

Place Hold on CALR mutations screening should not be studied in splanchnic vein thrombosis.

Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study.

By Castro Quismondo, Nerea. Haematologica, 2015 . 100(10):1294-300. , Formato Vancouver: Ocio EM, Herrera P, Olave MT, Castro N, Pérez Simón JA, Brunet S et al; PETHEMA Group. Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study. Haematologica. 2015 Oct;100(10):1294-300.

Place Hold on Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study.